These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8640460)

  • 1. Long-lasting inhibition of 5-HT uptake of platelets in subjects treated by duloxetine, a potential antidepressant.
    Kasahara T; Ishigooka J; Nagata E; Murasaki M; Miura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Feb; 16(1):25-31. PubMed ID: 8640460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of washing procedure on platelets pretreated with serotonin uptake inhibitors in vitro: low Ki values predict long-lasting inhibition of serotonin uptake in vivo.
    Ishigooka J; Kasahara T; Nagata E; Murasaki M; Miura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Feb; 18(1):19-21. PubMed ID: 9592808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain.
    Gould GG; Javors MA; Frazer A
    Biol Psychiatry; 2007 Jan; 61(2):210-5. PubMed ID: 16650830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine is both an inhibitor and a substrate of cytochrome P4502D6 in healthy volunteers.
    Skinner MH; Kuan HY; Pan A; Sathirakul K; Knadler MP; Gonzales CR; Yeo KP; Reddy S; Lim M; Ayan-Oshodi M; Wise SD
    Clin Pharmacol Ther; 2003 Mar; 73(3):170-7. PubMed ID: 12621382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous increases of extracellular monoamines in microdialysates from hypothalamus of conscious rats by duloxetine, a dual serotonin and norepinephrine uptake inhibitor.
    Engleman EA; Perry KW; Mayle DA; Wong DT
    Neuropsychopharmacology; 1995 Jul; 12(4):287-95. PubMed ID: 7576005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms for the inhibition of genital vascular responses by antidepressants in a female rabbit model.
    Angulo J; Cuevas P; Cuevas B; Gupta S; Sáenz de Tejada I
    J Pharmacol Exp Ther; 2004 Jul; 310(1):141-9. PubMed ID: 15034084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LY248686, a new inhibitor of serotonin and norepinephrine uptake.
    Wong DT; Bymaster FP; Mayle DA; Reid LR; Krushinski JH; Robertson DW
    Neuropsychopharmacology; 1993 Jan; 8(1):23-33. PubMed ID: 8424846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic treatment with duloxetine is necessary for an anxiolytic-like response in the mouse zero maze: the role of the serotonin transporter.
    Troelsen KB; Nielsen EØ; Mirza NR
    Psychopharmacology (Berl); 2005 Oct; 181(4):741-50. PubMed ID: 16032412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro.
    Goto S; Egashira T; Wada Y; Takayama F; Yamanaka Y
    Jpn J Pharmacol; 1996 Aug; 71(4):291-8. PubMed ID: 8886926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects.
    Chappell JC; Eisenhofer G; Owens MJ; Haber H; Lachno DR; Dean RA; Knadler MP; Nemeroff CB; Mitchell MI; Detke MJ; Iyengar S; Pangallo B; Lobo ED
    J Clin Psychopharmacol; 2014 Feb; 34(1):9-16. PubMed ID: 24346757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant-like effects of 071031B, a novel serotonin and norepinephrine reuptake inhibitor.
    Xue R; Jin ZL; Chen HX; Yuan L; He XH; Zhang YP; Meng YG; Xu JP; Zheng JQ; Zhong BH; Li YF; Zhang YZ
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):728-41. PubMed ID: 22748419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study.
    Chalon SA; Granier LA; Vandenhende FR; Bieck PR; Bymaster FP; Joliat MJ; Hirth C; Potter WZ
    Neuropsychopharmacology; 2003 Sep; 28(9):1685-93. PubMed ID: 12784100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term administration of duloxetine on the function of serotonin and noradrenaline terminals in the rat brain.
    Rueter LE; Kasamo K; de Montigny C; Blier P
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):600-10. PubMed ID: 9686935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of the serotonin and norepinephrine uptake processes by duloxetine: in vitro and in vivo studies in the rat brain.
    Kasamo K; Blier P; De Montigny C
    J Pharmacol Exp Ther; 1996 Apr; 277(1):278-86. PubMed ID: 8613930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects.
    Turcotte JE; Debonnel G; de Montigny C; Hébert C; Blier P
    Neuropsychopharmacology; 2001 May; 24(5):511-21. PubMed ID: 11282251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity.
    Vaishnavi SN; Nemeroff CB; Plott SJ; Rao SG; Kranzler J; Owens MJ
    Biol Psychiatry; 2004 Feb; 55(3):320-2. PubMed ID: 14744476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological characterization of the effect of long-term duloxetine administration on the rat serotonergic and noradrenergic systems.
    Rueter LE; De Montigny C; Blier P
    J Pharmacol Exp Ther; 1998 May; 285(2):404-12. PubMed ID: 9580577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative effects of duloxetine and desipramine on sleep EEG in healthy subjects.
    Chalon S; Pereira A; Lainey E; Vandenhende F; Watkin JG; Staner L; Granier LA
    Psychopharmacology (Berl); 2005 Feb; 177(4):357-65. PubMed ID: 15290000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression.
    Bymaster FP; Lee TC; Knadler MP; Detke MJ; Iyengar S
    Curr Pharm Des; 2005; 11(12):1475-93. PubMed ID: 15892657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine versus other anti-depressive agents for depression.
    Cipriani A; Koesters M; Furukawa TA; Nosè M; Purgato M; Omori IM; Trespidi C; Barbui C
    Cochrane Database Syst Rev; 2012 Oct; 10():CD006533. PubMed ID: 23076926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.